Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (14)
  1. 14. Englert, Y. (1987). Pregnancy-specific parameters after IVF. Fertility and sterility, 47(2), 360-361.
    2.   Participations à des congrès et colloques internationaux (252)
  2. 1. Horicks, F., Van Den Steen, G., Houben, S., Englert, Y., & Demeestere, I. (2015). GnRH analogues effects on follicular growth and their potential ovarian protection against alkylating agent in mice. Abstract session presented at Spring Meeting of the Belgian Society of Physiology and Pharmacology(24-04-2015)
  3. 2. Horicks, F., Bockstaele, L., Houben, S., Van Den Steen, G., Englert, Y., & Demeestere, I. (2014). Evaluation of the Cyclophosphamide gonadotoxicity and the protective effect of GnRH analogues in mice model. Poster présenté à la conférence World Congress in Reproductive Biology (3rd: 2-4/09/2014: Edimbourg).
  4. 3. Horicks, F., Bockstaele, L., Houben, S., Van Den Steen, G., Englert, Y., & Demeestere, I. (2013). Mice model for investigation of the gonadoprotective effects of the GnRH analogues during chemotherapy: is it relevant? Poster présenté à la conférence Ovarian Club III, The Inverse Pyramid: Regulatng Follicle Number and Oocyte Quality (3rd: November 14-16, 2013: Paris, France).
  5. 4. Demeestere, I., Brice, P., Peccatori, F. A., Kentos, A., Gaillard, I., Zachée, P., Casasnovas, O., Van Den Neste, E., Dechene, J., De Maertelaer, V., Bron, D., & Englert, Y. (2013). Triptorelin to prevent chemotherapy-induced ovarian failure in lymphoma patients: a prospective randomized study. Paper session presented at 3rd Wold Congress of the ISFP (International Society for Fertility Preservation) (7-9 November 2013: Valencia, Spain).
  6. 5. Alvaro Mercadal, B., Imbert, R., Demeestere, I., De Leener, A., Englert, Y., & Costagliola, S. (2012). AMH mutations with reduced in vitro bioactivity related to premature ovarian insuficiency. Abstract session presented at ESHRE annual meeting(28th: 01-04 Juillet 2012: Istanbul, Turquie)
  7. 6. Bockstaele, L., Barant, S., Tsepelidis, S., Dechene, J., & Englert, Y. (2011). Effects of GnRH analogues and hCG on the expression of AMH and aromatase in primary cultured human granulosa cells. Poster présenté à la conférence Journée de rencontre du TELEVIE (11/11/2011: Gembloux).
  8. 7. Alvaro Mercadal, B., Imbert, R., De Leener, A., Englert, Y., Costagliola, S., & Delbaere, A. (2011). Potentially damaging AMH variants in a premature ovarian cohort. Paper session presented at 27ème annual meeting ESHRE (4 juillet 2011: Stockolm, Suède).
  9. 8. Englert, Y., & Demeestere, I. (2011). The use of GnRH agonists and oral contraceptives for protection against chemotherapy. Paper session presented at Consensus meeting on Fertility preservation (June 6-7, 2011: Barcelona).
  10. 9. Pirson, M., Delo, C., Martins, D., Englert, Y., Marion, C., Nicolas, C., & Leclercq, P. (2011). Evaluation du coût de revient des accouchements et des césariennes, étude réalisée dans deux hôpitaux belges. Paper session presented at Colloque du Prisci (Bruxelles, site UCL).
  11. 10. Tsepelidis, S., Barant, S., Imbert, R., Flahaut, A., Gervy Decoster, C., & Englert, Y. (2011). Significant variations of Anti-Müllerian hormone serum levels during pregnancy and during oral contraception. Paper session presented at Thirty Years of Advances in Reproductive Endocrinology and ART: A Celebratory Congress (May 27-31, 2011: Montreal, Canada).
  12. 11. Alvaro Mercadal, B., Imbert, R., Demeestere, I., De Leener, A., Englert, Y., Costagliola, S., & Delbaere, A. (2011). Potentially damaging amh variants in a premature ovarian failure. Paper session presented at European Society of Human Reproduction and Embryology (2011).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 Suivant >>